Diabetic retinopathy

January 19, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Melatonin, Epicatechin and Matrine (MNEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 19/January/2018, 10.59 pm

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Melatonin, Epicatechin and Matrine (MNEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 19/January/2018, 10.59 pm https://genomediscovery.org/wp-content/uploads/2018/01/A-pharmaceutical-mixture-encompassing-Melatonin-Epicatechin-and-Matrine-MTEM-attenuates-diabetic-retinopathy-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/A-pharmaceutical-mixture-encompassing-Melatonin-Epicatechin-and-Matrine-MTEM-attenuates-diabetic-retinopathy-1.jpg January 19, 2018 January 19, 2018

Introduction: What they say A study from the Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany; and German Centre for Cardiovascular Research (DZHK) partner…

January 18, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing 15-Deoxy-Delta-12,14-prostaglandin J2 (15d-PGJ2), Epicatechin and Matrine (15d-GJ2EM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 18/January/2018, 12.05 pm

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing 15-Deoxy-Delta-12,14-prostaglandin J2 (15d-PGJ2), Epicatechin and Matrine (15d-GJ2EM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 18/January/2018, 12.05 pm https://genomediscovery.org/wp-content/uploads/2017/10/A-pharmaceutical-mixture-encompassing-15d-PGJ2-EM-Epicatechin-and-Matrine-15d-PGJ2-EM-protects-against-Diabetic-retinopathy.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/10/A-pharmaceutical-mixture-encompassing-15d-PGJ2-EM-Epicatechin-and-Matrine-15d-PGJ2-EM-protects-against-Diabetic-retinopathy.jpg January 18, 2018 January 18, 2018

January 17, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Lovastatin, Epicatechin and Matrine (LSEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 17/January/2018, 9.56 am

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Lovastatin, Epicatechin and Matrine (LSEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 17/January/2018, 9.56 am https://genomediscovery.org/wp-content/uploads/2018/01/LSEM-inhibits-EPHX2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/LSEM-inhibits-EPHX2.jpg January 17, 2018 January 17, 2018

January 15, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Simvastatin, Epicatechin and Matrine (SEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 16/January/2018, 5.22 am

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Simvastatin, Epicatechin and Matrine (SEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 16/January/2018, 5.22 am https://genomediscovery.org/wp-content/uploads/2018/01/SEM-inhibits-EPHX2-expression-decreases-1920-dihydroxydocosapentaenoic-acid-levels-promotes-pericite-viability-and-attenuates-the-development-of-diabetic-retina-5.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/SEM-inhibits-EPHX2-expression-decreases-1920-dihydroxydocosapentaenoic-acid-levels-promotes-pericite-viability-and-attenuates-the-development-of-diabetic-retina-5.jpg January 15, 2018 January 16, 2018

January 14, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Fluvastatin, Epicatechin and Matrine (ANEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 15/January/2018, 5.07 am

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Fluvastatin, Epicatechin and Matrine (ANEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 15/January/2018, 5.07 am https://genomediscovery.org/wp-content/uploads/2018/01/FNEM-inhibits-EPHX2-expression-decreases-1920-dihydroxydocosapentaenoic-acid-DHDP-levels-and-attenuates-the-development-of-diabetic-retina.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/FNEM-inhibits-EPHX2-expression-decreases-1920-dihydroxydocosapentaenoic-acid-DHDP-levels-and-attenuates-the-development-of-diabetic-retina.jpg2_.jpg January 14, 2018 January 14, 2018

January 13, 2018

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Atorvastatin, Epicatechin and Matrine (ANEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 13/January/2018, 11.34 pm

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing Atorvastatin, Epicatechin and Matrine (ANEM) inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 13/January/2018, 11.34 pm https://genomediscovery.org/wp-content/uploads/2018/01/ANEM-inhibits-EPHX2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/ANEM-inhibits-EPHX2.jpg January 13, 2018 January 13, 2018

Popular Post